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Background: Tuberculosis is a major health concern in Mexico, especially among the native population.
Tuberculomas are a frequent and severe complication of pediatric tuberculosis, these are observed as tumors in
neuroimaging studies but are often not diagnosed adequately.
Case presentation: We present a case of a 12-year-old native Mexican girl Huichol ethnicity diagnosed with a
large posterior fossa tuberculoma found by imaging. This tuberculoma was surgically removed. Histopathologic
examination and staining with hematoxylin and eosin, and Ziehl-Neelsen techniques of the surgical specimen were
performed. Cerebrospinal fluid was analyzed by using the newly available Xpert® MTB/RIF assay (Cepheid, Sunnyvale
CA, USA). Granulomatous inflammation with central caseous necrosis surrounded by edematous brain with reactive
gliosis and acid-fast bacilli were revealed on histopathologic analysis. Mycobacterium tuberculosis DNA susceptible
to rifampicin was detected in the patient’s cerebrospinal fluid and the patient was started on anti-tuberculosis
treatment. The girl continued to show severe neurologic damage despite surgery and anti-tuberculosis treatment,
and she eventually died of respiratory complications.
Conclusion: Our case highlights the need for early confirmation of tuberculoma diagnosis by molecular assay so
that timely treatment can be initiated to prevent severe brain damage. Furthermore, it emphasizes the need to
consider tuberculomas in the differential diagnosis of children with neurologic symptoms living in areas of high
tuberculosis incidence and those belonging to native populations in developing countries.
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Pediatric tuberculosis (TB) is a global health threat [1],
and tuberculomas are a frequent, severe complication of
TB in developing countries [2,3]. Intracranial tuberculo-
mas occur in as many as 13% of children with neurotuber-
culosis [4]; these are observed as tumors in neuroimaging
studies [5] but are often not detected at early stages, when
antitubercular therapy offers a high likelihood of cure
with minimal sequelae. Early diagnosis of tuberculomas
can be difficult; they generally remain undetectable until
they have grown sufficiently to cause neurologic signs and* Correspondence: grisesme@yahoo.com.mx
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article, unless otherwise stated.symptoms. Even a tumor detected by imaging cannot ne-
cessarily be attributed to TB because of frequent false-
negative tuberculin skin tests (TSTs), and the difficulty of
microscopic detection of TB in cerebrospinal fluid (CSF)
and the slow growth of the bacilli in culture media [1,2].
TB is a major health concern in Mexico [6], especially
among the native population [7]. We report the unusual
case of a native Huichol Mexican girl with a large pos-
terior fossa tuberculoma; her TB was diagnosed by
using the Xpert MTB/RIF assay, which amplifies DNA
from Mycobacterium tuberculosis and detects rifampin
resistance. The case presentation was approved by the
Ethics Committee in Biomedical Research of Hospital
Civil de Guadalajara.
Case presentation
A 12-year-old Huichol native Mexican girl was admitted
to the infectious disease ward of Hospital Civil deMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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in a stretcher by her grandparents, who were her care
providers. She had a history of headache, nausea, vomit-
ing, blurred vision, weakness, and ataxia. Four months
before admission she had begun complaining of head-
aches, which became progressively more intense, and
occasional nausea and vomiting. One month before ad-
mission she experienced blurred vision, progressive
weakness, and difficulty in walking and doing other
voluntary movement. She had no fever or cough. A
physician at the local healthcare center referred her to
Hospital Civil. Soon after referral she began experiencing
brief, generalized tonic-clonic seizures then, became too
weak to walk.
The patient had not received routine childhood immu-
nizations, including BCG vaccine. Her household pro-
vided poor living conditions, and her diet included
unpasteurized cow’s milk. At examination at the hos-
pital, the patient appeared emaciated: weight, 26 kg;
height, 150 cm; body mass index (BMI), 11.6 (reference
BMI for age, 18.5 – 24.9, by http://www.nhlbi.nih.gov/
guidelines/obesity/BMI/bmi-m.htm, accessed May 2,
2014). Her heart rate was 121/min, respiratory rate was
60/min, blood pressure was 70/40 mm Hg, and axillary
temperature was 36.3°C. She was unconscious and un-
responsive to verbal commands. The patient showed
constricted pupils unresponsive to light with bilateralFigure 1 Cranial magnetic resonance imaging of the tuberculoma and
T1-weighted and contrast-enhanced T1-weighted axial MRI revealed a large
displacing the fourth ventricle and pons. (C-D) Sagittal views show an inte
and causing hydrocephalus by compressing the fourth ventricle. (E) The su
bacilli observed by Ziehl–Neelsen staining (original magnification, ×100). (G
multinucleated Langhans giant cells forming a granulomatous lesion. Hemconvergent esotropia, generalized weakness, and bilat-
eral flexor plantar responses.
Cranial axial computed tomography (CT) with con-
trast revealed a posterior fossa mass and hydrocephalus,
confirmed by cranial magnetic resonance imaging (MRI)
with gadolinium. T1-weighted MRI revealed a large, well-
defined, heterogeneous mass in the right posterior fossa
with hyperdense rim enhancement and hydrocephalus
measuring 61 × 69 × 62 mm3 (Figure 1A-D). The lesion
was initially interpreted as a primary brain tumor
obstructing CSF circulation. A ventriculo-peritoneal shunt
was immediately placed. The patient received intravenous
mannitol 2 g/kg to reduce presumed cerebral edema. A
few days later, a spinal T1-weighted MRI revealed marked
gadolinium enhancement of the cervical, thoracic, and
lumbar dura, suggestive of an infectious process such as
TB. However, the TST was negative and the CSF con-
tained no leukocytes. The CSF protein concentration was
230 mg/dL; the CSF glucose (37 mg/dL) and plasma glu-
cose (113 mg/dL) ratio was 0.32 (reference range, >0.6).
Acid-fast bacilli (AFB) staining by the Ziehl–Neelsen tech-
nique and culture were negative.
Because of the diagnostic uncertainty, the tumor was
removed. It was revealed as a large, cheese-like mass
(Figure 1E). Histopathology, using hematoxylin-eosin stain-
ing and Ziehl–Neelsen staining, revealed granulomatous
inflammation with central caseous necrosis surrounded byhistopathologic studies of the surgical specimen. (A-B)
(61 × 69 × 62 mm) heterogeneous lesion that was contralaterally
nsely gadolinium-enhanced lesion occupying the entire posterior fossa
rgical specimen comprised a caseous-appearing material. (F) Acid-fast
) Lymphoplasmacytic inflammation containing epithelioid cells and
atoxylin and eosin staining (original magnification, ×10).
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AFB (Figure 1F-G). Rifampicin-susceptible M. tuberculosis
was detected in the CSF by using the newly available Xpert
MTB/RIF assay, confirming the diagnosis of central ner-
vous system (CNS) TB. A chest CT, 10 days after admis-
sion, revealed consolidation in the basal left lung, but
Ziehl–Neelsen staining and TB DNA amplification of bron-
chial and gastric aspirates with the Xpert MTB/RIF assay
were negative for M. tuberculosis. Although her grandpar-
ents did not exhibit symptoms of TB, her community
health department was notified to test other family mem-
bers for TB (results not available).
The patient begun on 10 mg/kg/day isoniazid, 20 mg/
kg/day rifampicin, 35 mg/kg/day pyrazinamide, and
20 mg/kg/day ethambutol. In addition, dexamethasone
was added for the treatment of CNS TB. Serology was
negative for human deficiency virus infection. One
month after surgery and start of anti-TB treatment, the
patient remained neurologically unchanged: uncon-
scious, pupils unresponsive to light, bilateral esotropia,
generalized weakness, and bilateral flexor plantar re-
sponse. She was unable to communicate and was fed via
orogastric tube. A cranial CT scan found no residual or
new lesions or contrast enhancement at the original site.
The patient was cared for by team of infectious disease
and multispecialty experts at Hospital Civil and medical
care and medications were free. After three months, the
grandparents requested a transfer to a hospital closer to
her community. Six months after transfer, the patient
died of respiratory complications. The Ethics Committee
in Biomedical Research of Hospital Civil de Guadalajara
granted permission and approval to review the patient’s
clinical information.
Discussion
In Mexico, native ethnic groups comprise 10% of the
population [8] and have a higher incidence of TB [7] for
reasons including genetic predisposition, lifestyle, limited
healthcare access, and poverty [9]. The case we present
is unusually advanced, even in such a medically under-
served population and illustrates how healthcare defi-
ciencies can affect children in low-income populations,
such as late access to appropriate medical care and TB
prevention. At the same time, it demonstrates the im-
portance of a rapid, highly sensitive and specific diagnos-
tic test for neurotuberculosis.
Our patient was severely malnourished, suggesting a
long evolution of the disease. Thus, malnutrition, and
consequently her immunocompromised condition, may
explain her anergy to the TST. False-negative tuberculin
reactions occur frequently in patients with advanced
malnutrition [1,2]. Our patient’s extent of neurological
damage also indicated a long disease evolution. Her nega-
tive TST and the tuberculoma’s site may have delayedclinical suspicion until the CSF obstruction caused
hydrocephalous [1]. Therefore, tuberculomas should
be considered in the differential diagnosis of brain tu-
mors in children living in TB-prone areas and in high-
risk groups such as native populations in developing
countries.
The patient’s neurologic symptoms evolved, in the
absence of fever, for 4 months before hospitalization,
consistent with the reported development of brain
tuberculomas 2 to 6 months after TB infection [1].
Tuberculomas are granulomatous tumor-like mass
that is not a cancer that results from infection with
Mycobacterium tuberculosis. This lesion is composed
of a central zone of caseation surrounded by collage-
nous tissue capsule that usually develop in the CNS or
lungs [4,5]. After hematogenous dissemination, the ba-
cilli multiply locally and produce pathologic growth
via chronic inflammation and aggregation of caseated
granulomas [5]. A mass located in CNS structures fre-
quently manifests as an intracranial space-occupying
lesion [10,11]. Therefore, tuberculoma should be a dif-
ferencial diagnosis in patients with these intracranial
lesions and severe neurologic damage where the risk
TB is high, even in the absence of fever or other TB
symptoms.
CT and MRI revealed a large mass in the posterior
fossa, despite a negative TST and acid-fast CSF stain.
Fortunately, the newly available MTB/RIF assay revealed
TB. Despite its high sensitivity (100%) and specificity
(85.7%) in diagnosing tuberculoma, CT has a low posi-
tive predictive value (33%) [10]. CT and MRI images are
suggestive of malignant tumors, but MRI offers greater
inherent sensitivity and specificity [11]. Moreover, trad-
itional microbiologic tests for TB in the CSF have low
sensitivity (26% to 37%) [1] and mycobacteria grow
slowly in culture [2]. Our patient’s CSF stain was nega-
tive for AFB until subsequent testing by Xpert MTB/RIF
amplification. AFBs were detected in the excised tuber-
culoma and the histopathologic studies demonstrated
caseating granulomas and mycobacteria [1]. These stud-
ies are recommended in all suspected cases of TB similar
to our case. The Xpert MBT/RIF kit has moderate
sensitivity (59.3% to 81.3%) and high specificity (99.5%
to 100%) in CSF specimens [12,13]. It also rapidly de-
tects M. tuberculosis in CSF and tissue specimens and
should be compared with histopathologic findings
[1,5]. In Mexico, as in many countries in the Americas,
this TB diagnostic test was introduced as part of the pro-
grammatic management of multidrug-resistant TB (http://
www.paho.org/hq/index.php?option=com_docman&task=
doc_view&gid=24329&Itemid=). This assay is recom-
mended for use in CSF and tissue specimens by the
World Health Organization guidelines for national
pediatric tuberculosis programs [14].
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the CSF obstruction and TB, our patient’s prognosis
remained poor because of the tuberculoma’s size and
neurologic sequelae. Her neurologic abnormalities were
unremitting, and she died of respiratory complications,
most likely related to chronic aspiration and infections.
Risk factors for her poor outcome included the tubercu-
loma’s size, location, and lengthy evolution, and her mal-
nourished condition. Other risk factors for an invasive
TB and CNS infection is the lack of BCG vaccination,
which has been reported to be protective for neurotu-
berculosis and miliary TB [1,2]. Our case highlights
the importance of BCG vaccination of children in TB-
endemic regions and native ethnic groups in developing
countries.
Conclusion
Therefore, in areas with endemic TB, tuberculomas should
be suspected in children with associated risk factors for
TB infection [3,5] and intracranial tumors. In clinically
suspected cases, molecular assays now allow early diagno-
sis in CSF and tissues, facilitating timely treatment and
prevention of severe brain damage and death.
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